EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Allergen‐Specific Human Monoclonal IgG Antibodies for Use in Passive Allergy Immunotherapy

Scott A Smith, Cosby A Stone, Alain Jacquet iD

Clinical & Experimental Allergy · 2025

DOI: 10.1111/cea.70153 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical & Experimental Allergy, 2025. Verfasst von Scott A Smith und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Allergens, Immunoglobulin G, Antibodies, Monoclonal, Immunization, Passive. Die Arbeit nennt 67 Literaturangaben. Gefördert von: Thailand Science Research and Innovation (TSRI) Fund Chulalongkorn University, 90th Anniversary of Chulalongkorn University Ratchadaphiseksomphot Fund, Thailand Science Research and Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The last decades have shown the number of subjects developing allergic rhinitis (AR), allergic asthma (AA), atopic dermatitis (AD), and food allergy rose continuously worldwide. To cure these allergic diseases, allergen‐specific immunotherapy (AIT) represents the unique treatment capable of providing clinical outcomes through the induction of long‐term immunological tolerance. Despite proven efficacy, the duration of treatment, AIT‐associated side effects, and the difficulty in identifying potential responders by diagnosis lead to poor patient compliance. Clinical investigations evidenced the role of blocking IgG antibodies induced by AIT in long‐term tolerance. These observations suggested that passive allergy immunotherapy (PAIT) with low doses of allergen‐specific blocking IgG antibodies represents an elegant alternative to frequent administrations of allergen extracts. Tremendous technological progress in the discovery/production of fully human monoclonal antibodies (mAbs) with very low immunogenicity has been made in the last decades, and these therapeutic antibodies revolutionised the treatment of cancers or infectious diseases. The recent advances in the isolation of rare allergen‐specific IgE+ B cells and the generation of human antibodies in transgenic mice made possible the production of human monoclonal blocking antibodies against any allergen, sharing the same affinity with the corresponding naturally occurring IgE. This comprehensive review will describe the first promising preclinical and clinical data obtained with antibody cocktails targeting several IgE epitopes to some key single allergens. PAIT is safe and effective for the downregulation of the allergic response. Compared with conventional extract‐based AIT, the positive outcomes could require much less dosing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AllergensImmunoglobulin GAntibodies, MonoclonalImmunization, PassiveHypersensitivityDesensitization, ImmunologicHumansAnimalsImmunoglobulin E

Stichwörter der Autor:innen

IgE monoclonal antibodiesIgG blocking antibodiesallergenic epitopespassive allergy immunotherapy

Substanzen

AllergensImmunoglobulin GAntibodies, MonoclonalImmunoglobulin E

Autor:innen und Institutionen

  • Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Division of Allergy and Clinical Immunology, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.
  • Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

ORCID-Profile: Alain Jacquet

Förderung

  • Thailand Science Research and Innovation (TSRI) Fund Chulalongkorn University
  • 90th Anniversary of Chulalongkorn University Ratchadaphiseksomphot Fund
  • Thailand Science Research and Innovation

Zitieren

APA

Smith, S. A., Stone, C. A., & Jacquet, A. (2025). Allergen‐Specific Human Monoclonal IgG Antibodies for Use in Passive Allergy Immunotherapy. Clinical & Experimental Allergy. https://doi.org/10.1111/cea.70153

Vancouver

Smith SA, Stone CA, Jacquet A. Allergen‐Specific Human Monoclonal IgG Antibodies for Use in Passive Allergy Immunotherapy. Clinical & Experimental Allergy. 2025. doi:10.1111/cea.70153

BibTeX
@article{Smith2025,
  author = {Smith, Scott A and Stone, Cosby A and Jacquet, Alain},
  title = {Allergen‐Specific Human Monoclonal IgG Antibodies for Use in Passive Allergy Immunotherapy},
  journal = {Clinical & Experimental Allergy},
  year = {2025},
  doi = {10.1111/cea.70153}
}
Kostenlos starten →